European Heart Journal Advance Access published online on March 1, 2006
European Heart Journal, doi:10.1093/eurheartj/ehi818
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Boston Scientific Corporation, Natick, MA, USA
* To whom correspondence should be addressed. Aims Mesenchymal stem cells (MSCs), rare bone marrow-derived stem cell precursors of non-haematopoietic tissues, have shown promise in potentially repairing infarcted myocardium. These and similar cell types are being tested clinically, but understanding of delivery and subsequent biodistribution is lacking. This study was designed to quantitatively compare MSC engraftment rates after intravenous (IV), intracoronary (IC), or endocardial (EC) delivery in a porcine myocardial infarction (MI) model. Methods and results Allogeneic, male MSCs were cultured from porcine bone marrow aspirates. Iridium nanoparticles were added during culturing and internalized by the MSCs. An MI was induced in female swine (27-40 kg in size) by prolonged balloon occlusion of the mid-left anterior descending artery. Animals (n = 6 per group) were randomized to one of three delivery methods. Cellular engraftment was determined 14 ± 3 days post-delivery by measuring ex-vivo the iridium nanoparticle concentration in the infarct. Confirmation of cellular engraftment utilized both DiI and fluorescence in situ hybridization (FISH) labelling techniques. During MSC infusion, no adverse events were noted. However, following IC infusion, half of the pigs exhibited decreased blood flow distal to the infusion site. At 14 days, the mean number of engrafted cells within the infarct zone was significantly greater (P Conclusion IC and EC injection of MSCs post-MI resulted in increased engraftment within infarcted tissue when compared with IV infusion, and IC was more efficient than EC. However, IC delivery was also associated with a higher incidence of decreased coronary blood flow. EC delivery into acutely infarcted myocardial tissue was safe and well tolerated and was associated with decreased remote organ engraftment with compared with IC and IV deliveries.
Received December 12, 2005
Revised January 31, 2006
Accepted February 9, 2006
Preclinical research
A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction
Toby Freyman 1,
Glenn Polin 2,
Hashim Osman 2,
Jody Crary 1,
MinMin Lu 2,
Lan Cheng 2,
Maria Palasis 1,
and
Robert L. Wilensky 2 *
2 Cardiovascular Division, Hospital of the University of Pennsylvania, University of Pennsylvania Medical Center, 3400 Spruce Street, 9 Gates, Philadelphia, PA 19104, USA
Robert L. Wilensky, E-mail: robert.wilensky{at}uphs.upenn.edu
Abstract 
0.01) following IC infusion than either EC injection or IV infusion and EC engraftment was greater than IV engraftment (P 0.01). There was less systemic delivery to the lungs following [EC vs. IV (P = 0.02), EC vs. IC (P = 0.06)]. Both DiI and FISH labelling demonstrated the presence of engrafted male MSCs within the female infarcted tissue.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. J. Blackwood, B. Lewden, R. G. Wells, J. Sykes, R. Z. Stodilka, G. Wisenberg, and F. S. Prato In Vivo SPECT Quantification of Transplanted Cell Survival After Engraftment Using 111In-Tropolone in Infarcted Canine Myocardium J. Nucl. Med., June 1, 2009; 50(6): 927 - 935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Menasche Stem Cell Therapy for Heart Failure: Are Arrhythmias a Real Safety Concern? Circulation, May 26, 2009; 119(20): 2735 - 2740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-H. Li, T. Y.Y. Lai, Z. Sun, M. Han, E. Moriyama, B. Wilson, S. Fazel, R. D. Weisel, T. Yau, J. C. Wu, et al. Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery. J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1225 - 33.e1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Mollmann, H. Nef, A. Elsasser, and C. Hamm Stem cells in myocardial infarction: from bench to bedside Heart, March 1, 2009; 95(6): 508 - 514. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Toma, W. R. Wagner, S. Bowry, A. Schwartz, and F. Villanueva Fate Of Culture-Expanded Mesenchymal Stem Cells in The Microvasculature: In Vivo Observations of Cell Kinetics Circ. Res., February 13, 2009; 104(3): 398 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Vela, G. V. Silva, J. A.R. Assad, A. L.S. Sousa, S. Coulter, M. R. Fernandes, E. C. Perin, J. T. Willerson, and L. M. Buja Histopathological Study of Healing After Allogenic Mesenchymal Stem Cell Delivery in Myocardial Infarction in Dogs J. Histochem. Cytochem., February 1, 2009; 57(2): 167 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ota, N. A. Patronik, D. Schwartzman, C. N. Riviere, and M. A. Zenati Minimally Invasive Epicardial Injections Using a Novel Semiautonomous Robotic Device Circulation, September 30, 2008; 118(14_suppl_1): S115 - S120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L M A Beeres, D. E Atsma, J. van Ramshorst, M. J Schalij, and J. J Bax Cell therapy for ischaemic heart disease Heart, September 1, 2008; 94(9): 1214 - 1226. [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Psaltis, A. C.W. Zannettino, S. G. Worthley, and S. Gronthos Concise Review: Mesenchymal Stromal Cells: Potential for Cardiovascular Repair Stem Cells, September 1, 2008; 26(9): 2201 - 2210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Tossios, B. Krausgrill, M. Schmidt, T. Fischer, M. Halbach, J. W.U. Fries, S. Fahnenstich, P. Frommolt, I. Heppelmann, A. Schmidt, et al. Role of balloon occlusion for mononuclear bone marrow cell deposition after intracoronary injection in pigs with reperfused myocardial infarction Eur. Heart J., August 1, 2008; 29(15): 1911 - 1921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Hashemi, S. Ghods, F. D. Kolodgie, K. Parcham-Azad, M. Keane, D. Hamamdzic, R. Young, M. K. Rippy, R. Virmani, H. Litt, et al. A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction Eur. Heart J., January 2, 2008; 29(2): 251 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhang, P. Song, Y. Tang, X.-l. Zhang, S.-h. Zhao, Y.-j. Wei, and S.-s. Hu Injection of bone marrow mesenchymal stem cells in the borderline area of infarcted myocardium: heart status and cell distribution. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1234 - 1240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Valina, K. Pinkernell, Y.-H. Song, X. Bai, S. Sadat, R. J. Campeau, T. H. Le Jemtel, and E. Alt Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction Eur. Heart J., November 1, 2007; 28(21): 2667 - 2677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Duncker, A. Uitterdijk, and W. J. Van der Giessen Fat is not all bad: how to make good use of adipose tissue Eur. Heart J., November 1, 2007; 28(21): 2565 - 2567. [Full Text] [PDF]
|
|
|
|
|
|
G. Chamberlain, J. Fox, B. Ashton, and J. Middleton Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing Stem Cells, November 1, 2007; 25(11): 2739 - 2749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Simpson, H. Liu, T.-H. M. Fan, R. Nerem, and S. C. Dudley Jr. A Tissue Engineering Approach to Progenitor Cell Delivery Results in Significant Cell Engraftment and Improved Myocardial Remodeling Stem Cells, September 1, 2007; 25(9): 2350 - 2357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. He, C. Wan, and G. Li Concise Review: Multipotent Mesenchymal Stromal Cells in Blood Stem Cells, January 1, 2007; 25(1): 69 - 77. [Abstract] [Full Text] [PDF]
|
|